239 related articles for article (PubMed ID: 25494887)
1. [Epidemiology of screening-targeted cancers according to new data of the Czech National Cancer Registry].
Dušek L; Mužík J; Malúšková D; Májek O; Pavlík T; Koptíková J; Gregor J; Brabec P; Abrahámová J
Klin Onkol; 2014; 27 Suppl 2():19-39. PubMed ID: 25494887
[TBL] [Abstract][Full Text] [Related]
2. [Results of the Czech National Colorectal Cancer screening programme - faecal occult blood tests].
Seifert B; Májek O; Zavoral M; Král N; Suchánek S; Ngo O; Dušek L
Klin Onkol; 2014; 27 Suppl 2():87-97. PubMed ID: 25494893
[TBL] [Abstract][Full Text] [Related]
3. [Results of the Czech National Breast Cancer screening programme].
Skovajsová M; Májek O; Daneš J; Bartoňková H; Ngo O; Dušek L
Klin Onkol; 2014; 27 Suppl 2():69-78. PubMed ID: 25494891
[TBL] [Abstract][Full Text] [Related]
4. [Results of the Czech National Colorectal Cancer Screening Programme - colonoscopy examinations].
Suchánek S; Májek O; Zavoral M; Seifert B; Ngo O; Dušek L
Klin Onkol; 2014; 27 Suppl 2():98-105. PubMed ID: 25494894
[TBL] [Abstract][Full Text] [Related]
5. [Approach to population-based screening in the Czech Republic, methodology and first results of the personalised invitation of citizens to cancer screening programmes].
Dušek L; Májek O; Bláha M; Daneš J; Zavoral M; Seifert B; Dvořák V; Skovajsová M; Suchánek S; Jung T; Brzková M; Klika P; Klimeš D; Koptíková J; Gregor J
Klin Onkol; 2014; 27 Suppl 2():59-68. PubMed ID: 25494890
[TBL] [Abstract][Full Text] [Related]
6. [Results of the Czech National Cervical Cancer screening programme].
Dušková J; Beková A; Dvořák V; Májek O; Dušek L
Klin Onkol; 2014; 27 Suppl 2():79-86. PubMed ID: 25494892
[TBL] [Abstract][Full Text] [Related]
7. [Performance indicators in screening programmes].
Májek O; Ngo O; Daneš J; Zavoral M; Dvořák V; Klimeš D; Dušek L
Klin Onkol; 2014; 27 Suppl 2():106-12. PubMed ID: 25494895
[TBL] [Abstract][Full Text] [Related]
8. Estimating cancer incidence, prevalence, and the number of cancer patients treated with antitumor therapy in 2015 and 2020 - analysis of the Czech National Cancer Registry.
Dusek L; Pavlík T; Májek O; Büchler T; Muzik J; Maluskova D; Koptíková J; Bortlicek Z; Abrahámová J
Klin Onkol; 2015; 28(1):30-43. PubMed ID: 25692753
[TBL] [Abstract][Full Text] [Related]
9. Cancer incidence and mortality in the Czech Republic.
Dusek L; Muzik J; Maluskova D; Májek O; Pavlík T; Koptíková J; Melichar B; Büchler T; Fínek J; Cibula D; Babjuk M; Svoboda M; Vyzula R; Ryska A; Ryska M; Petera J; Abrahámová J
Klin Onkol; 2014; 27(6):406-23. PubMed ID: 25493580
[TBL] [Abstract][Full Text] [Related]
10. [Epidemiology of cancers with implemented screening programmes in an international comparison].
Dušek L; Mužík J; Malúšková D; Gregor J
Klin Onkol; 2014; 27 Suppl 2():40-8. PubMed ID: 25494888
[TBL] [Abstract][Full Text] [Related]
11. Trends in stage-specific population-based survival of cancer patients in the Czech Republic in the period 2000-2008.
Pavlík T; Májek O; Büchler T; Vyzula R; Petera J; Ryska M; Ryška A; Cibula D; Babjuk M; Abrahámová J; Vorlíček J; Mužík J; Dušek L
Cancer Epidemiol; 2014 Feb; 38(1):28-34. PubMed ID: 24315848
[TBL] [Abstract][Full Text] [Related]
12. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
Hristova L; Hakama M
Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
[TBL] [Abstract][Full Text] [Related]
13. Performance indicators in a newly established organized cervical screening programme: registry-based analysis in the Czech Republic.
Májek O; Dušková J; Dvořák V; Beková A; Klimeš D; Blaha M; Anttila A; Dušek L
Eur J Cancer Prev; 2017 May; 26(3):232-239. PubMed ID: 26908155
[TBL] [Abstract][Full Text] [Related]
14. [State and development of background information for the evaluation of Czech cancer screening programmes].
Dušek L; Májek O; Klimeš D; Bláha M; Brabec P; Gregor J
Klin Onkol; 2014; 27 Suppl 2():49-58. PubMed ID: 25494889
[TBL] [Abstract][Full Text] [Related]
15. [Malignant tumors of the esophagus in the Czech Republic].
Duda M; Adamcík L; Dusek L; Skrovina M; Jínek T
Rozhl Chir; 2012 Mar; 91(3):132-40. PubMed ID: 22881077
[TBL] [Abstract][Full Text] [Related]
16. Colorectal cancer prevention in the Czech Republic: time trends in performance indicators and current situation after 10 years of screening.
Suchanek S; Majek O; Vojtechova G; Minarikova P; Rotnaglova B; Seifert B; Minarik M; Kozeny P; Dusek L; Zavoral M
Eur J Cancer Prev; 2014 Jan; 23(1):18-26. PubMed ID: 24129196
[TBL] [Abstract][Full Text] [Related]
17. Cervical cancer screening in the Czech Republic.
Tachezy R; Rob L
Coll Antropol; 2007 Apr; 31 Suppl 2():27-9. PubMed ID: 17598501
[TBL] [Abstract][Full Text] [Related]
18. [The strategy of the Czech Society for Oncology of the Czech Medical Association of J. E. Purkyně for the organisation of oncological care in the Czech Republic].
Vorlíček J
Vnitr Lek; 2013 Aug; 59(8):730-7. PubMed ID: 24007232
[TBL] [Abstract][Full Text] [Related]
19. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
20. [Trends in cancer incidence in the Czech Republic].
Zaloudík J; Geryk E; Vyzula R; Dusek L
Vnitr Lek; 2001 Aug; 47(8):516-8. PubMed ID: 15633387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
